Zhongguancun Science-Tech Leasing Co Ltd
HKEX:1601
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zhongguancun Science-Tech Leasing Co Ltd
HKEX:1601
|
CN |
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
US |
Cash Flow Statement
Cash Flow Statement
Zhongguancun Science-Tech Leasing Co Ltd
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
185
|
0
|
216
|
0
|
262
|
0
|
301
|
0
|
346
|
0
|
362
|
0
|
|
| Depreciation & Amortization |
11
|
0
|
14
|
0
|
19
|
0
|
20
|
0
|
16
|
0
|
21
|
0
|
|
| Other Non-Cash Items |
249
|
0
|
240
|
0
|
234
|
0
|
261
|
0
|
310
|
0
|
303
|
0
|
|
| Cash Taxes Paid |
52
|
80
|
52
|
70
|
73
|
86
|
98
|
97
|
107
|
100
|
100
|
116
|
|
| Cash Interest Paid |
213
|
199
|
204
|
191
|
212
|
218
|
223
|
246
|
246
|
287
|
327
|
310
|
|
| Change in Working Capital |
(1 005)
|
(461)
|
(433)
|
(328)
|
(1 192)
|
(293)
|
(1 253)
|
(1 019)
|
(1 308)
|
328
|
(549)
|
11
|
|
| Cash from Operating Activities |
(559)
N/A
|
(237)
+58%
|
37
N/A
|
(328)
N/A
|
(676)
-106%
|
(293)
+57%
|
(671)
-129%
|
(1 019)
-52%
|
(636)
+38%
|
328
N/A
|
137
-58%
|
11
-92%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(5)
|
(6)
|
(10)
|
(9)
|
(6)
|
(6)
|
(9)
|
(9)
|
(32)
|
(47)
|
(59)
|
(263)
|
|
| Other Items |
(50)
|
(50)
|
(24)
|
(25)
|
(25)
|
(15)
|
(59)
|
(21)
|
(14)
|
(121)
|
(28)
|
33
|
|
| Cash from Investing Activities |
(55)
N/A
|
(55)
-1%
|
(34)
+39%
|
(34)
-1%
|
(31)
+10%
|
(21)
+31%
|
(68)
-220%
|
(30)
+56%
|
(46)
-55%
|
(169)
-264%
|
(87)
+49%
|
(230)
-166%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
447
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
510
|
|
| Net Issuance of Debt |
826
|
271
|
(18)
|
518
|
1 215
|
627
|
1 007
|
1 521
|
1 008
|
150
|
574
|
738
|
|
| Cash Paid for Dividends |
0
|
0
|
(50)
|
0
|
(58)
|
0
|
(60)
|
0
|
(80)
|
0
|
(91)
|
0
|
|
| Other |
(266)
|
160
|
(221)
|
(643)
|
(212)
|
(218)
|
(223)
|
(246)
|
(246)
|
(287)
|
(327)
|
(310)
|
|
| Cash from Financing Activities |
560
N/A
|
431
-23%
|
158
-63%
|
272
+72%
|
944
+247%
|
351
-63%
|
724
+106%
|
1 215
+68%
|
682
-44%
|
(217)
N/A
|
156
N/A
|
847
+442%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
|
| Net Change in Cash |
(55)
N/A
|
139
N/A
|
161
+16%
|
(90)
N/A
|
237
N/A
|
38
-84%
|
(15)
N/A
|
166
N/A
|
0
-100%
|
(58)
N/A
|
206
N/A
|
627
+205%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(565)
N/A
|
(243)
+57%
|
27
N/A
|
(338)
N/A
|
(682)
-102%
|
(299)
+56%
|
(680)
-128%
|
(1 028)
-51%
|
(667)
+35%
|
280
N/A
|
78
-72%
|
(252)
N/A
|
|